A 4-year-old girl is evaluated in the developmental clinic. Her parents report that she speaks in complete sentences but has difficulty understanding social cues and maintaining friendships. She is preoccupied with memorizing facts about dinosaurs and becomes upset if her daily routine is altered. She makes minimal eye contact and does not engage in imaginative play with peers. Her nonverbal IQ is 110 and verbal IQ is 115. Hearing and vision are normal. What is the most appropriate next step in management?

Explanation

## Management of Autism Spectrum Disorder: Evidence-Based Approach ### Diagnostic Context This child meets criteria for **Autism Spectrum Disorder, Level 1** (requiring support in social communication): - Persistent deficits in social communication (difficulty with social cues, minimal eye contact, no imaginative play with peers) - Restricted/repetitive interests (preoccupation with dinosaurs) - Behavioral rigidity (distress with routine changes) - **Preserved cognitive ability** (IQ 110–115, indicating average to above-average intelligence) **Key Point:** The presence of average or above-average IQ does NOT eliminate the diagnosis of ASD and does NOT predict spontaneous resolution of core deficits. ### First-Line Intervention: Behavioral Therapy **High-Yield:** The gold standard for ASD across all age groups and IQ levels is **early intensive behavioral intervention**, most commonly: - **Applied Behavior Analysis (ABA)** — evidence-based, structured, measurable outcomes - **Social skills training** — targeting peer interaction, emotion regulation, theory of mind - **Parent-mediated intervention** — coaching parents to reinforce skills across settings - **Occupational and speech therapy** as indicated ### Why Behavioral Intervention Is First-Line | Intervention | Evidence | Timing | Indication | |--------------|----------|--------|------------| | Behavioral therapy (ABA, social skills) | Strong RCT evidence | Start as early as possible | All children with ASD | | Psychoeducational testing | Supportive (not diagnostic) | After ASD diagnosis confirmed | If learning disability suspected | | Antipsychotics (risperidone, aripiprazole) | Moderate evidence | Reserved for specific symptoms | Severe aggression, self-injury, severe behavioral rigidity (not first-line) | | Reassurance/watchful waiting | No evidence | Not recommended | Delays intervention; core deficits persist | **Clinical Pearl:** Early intervention (ages 2–5) has the strongest evidence for improving long-term outcomes in social communication, adaptive functioning, and school readiness. Delaying treatment or assuming "outgrowing" the condition is not supported by evidence. ### Why Medication Is Not First-Line **Warning:** Antipsychotics (risperidone, aripiprazole) are FDA-approved for irritability in autism but are NOT first-line and carry risks (weight gain, metabolic syndrome, tardive dyskinesia). They are reserved for: - Severe aggression or self-injurious behavior - Severe behavioral rigidity unresponsive to behavioral intervention - Co-occurring psychiatric conditions (ADHD, anxiety) This child does not present with severe behavioral disturbance warranting medication initiation. ### Prognosis Does Not Depend on IQ Alone **Key Point:** While higher IQ is associated with better outcomes, core social and communication deficits persist into adulthood without intervention. Many high-IQ individuals with autism experience significant social isolation and mental health comorbidities (anxiety, depression) if social skills are not actively taught. [cite:American Academy of Pediatrics Clinical Practice Guideline on Autism, 2020; Dawson et al. JAMA 2010]